Search
Search Results
##search.searchResults.foundPlural##
-
-
PROPHYLAXIS OF MALARIA
2967PDF: 997HTML: 17777Figures SChwartz: 150 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
935PDF: 498HTML: 66 -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2197PDF: 839HTML: 2067 -
Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia
2876PDF: 669HTML: 1920figure 1: 154figure 2: 168 -
Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.
1308PDF: 812HTML: 10022cover letter to the editor: 153tile page: 238 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3180PDF: 1305HTML: 4108 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3542PDF: 1089HTML: 23319 -
VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES
1207PDF: 635HTML: 7711 -
The EVOLVING ROLE OF HAEMATOLOGY NURSING PRACTICE: A CROSS-SECTIONAL SURVEY
1691Suppl. Files: 837HTML: 405PDF: 710 -
Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: A Nationwide Iranian Experience Coronavirus in patients with thalassemias
1302PDF: 439HTML: 154 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2535PDF: 1573HTML: 2340Table1: 180 -
THALASSEMIA AND VENOUS THROMBOEMBOLISM
2880PDF: 990HTML: 4564 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1189PDF: 942HTML: 192 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2646PDF: 983HTML: 2217 -
Guest Editor: G. Castaman AGING WITH HEMOPHILIA: THE CHALLENGE OF APPROPRIATE DRUG PRESCRIPTION Hemophilia and aging
1622PDF: 1415HTML: 235 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1293PDF: 775HTML: 296 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4001PDF: 1888HTML: 1749 -
SICKLE CELL ANAEMIA AND MALARIA
11217PDF: 6867HTML: 23792Figures Malaria and SCK: 192 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2752PDF: 905HTML: 7307 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1391PDF: 1023HTML: 207 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4370PDF: 1878HTML: 17712 -
IMMUNOLOGY OF TUBERCULOSIS
5158PDF: 1969HTML: 7254Untitled: 188 -
-
Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia
7781PDF: 699HTML: 198 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2387PDF: 1262HTML: 1729CoverLetter: 161 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
2974PDF: 1002HTML: 3061 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1468PDF: 695HTML: 216







